Novavax and FUJIFILM Diosynth Biotechnologies initiated large scale manufacturing of COVID-19 vaccine candidate
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
AXIM Biotechnologies released Rapid NeuCovix test results showing strong agreement with COVID-19-based neutralization tests
On Jul. 23, 2020, AXIM Biotechnologies announced development of NeuCovixTM, a rapid diagnostic test measuring levels of functional…
Biotechnology | COVID-19 | FDA | Life Science News | Medicine | Therapeutics | Vaccine
Medigen Vaccines collaborated with Dynavax to develop novel adjuvanted COVID-19 vaccine candidate
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics (MVC) announced a collaboration to develop an adjuvanted…
Evotec Biologics awarded $18.2 million DoD contract to produce monoclonal antibody products against COVID-19
On Jul. 22, 20120, Evotec announced that the U.S. Department of Defense (DoD) had awarded its Seattle-based subsidiary,…
RedHill Biopharma accelerated phase 2/3 COVID-19 program with addition of Brazil and Mexico
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
Findings from real-world data study reveal higher risk of hospitalization and death among cancer patients with COVID-19
On Jul. 22, 2020, the FDA announced the data analyzed in collaboration with Syapse revealed a stark reality…
COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response
On Jul. 22, 2020, the WHO and UNICEF announced the COVID-19 Law Lab initiative which will gather and…
University of British Columbia scientists sequenced the genomes of Canadians with COVID-19
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…
Preclinical study showed SARS-CoV-2 spike protein licensed by Oragenics from NIH produces neutralizing antibodies
On Jul. 22, 2020, Oragenics announced that the National Institutes of Health created stabilized pre-fusion spike protein (CoV-2…
Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDļ¾ single dose intranasal vaccine candidate for COVID-19
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneļ¾s single-dose intranasal vaccine…
Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment
On Jul. 22, 2020, a new study led by Albert Einstein College of Medicine and Montefiore Health System…
Experimental Coronavirus vaccine is safe and produced immune response
On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…
Experimental coronavirus vaccine reported safe and produces immune response
On Jul. 21, 2020, researchers from the National Institutes of Health (NIH) announced that early results from the…
Mesa Biotech received $154 million funding from the NIH for accelerated scale-up and deployment
On Jul. 21, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…
Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samples
On Jul. 21, 2020, Bio-Techne announced that Exosome Diagnostics, a Bio-Techne brand, had completed validation testing for COVID-19…
COVID-19 vaccine trials conducted at Washington University, Saint Louis University
On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…
The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…
FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19
On Jul. 20, 2020, Sorrento announced that it had entered into a binding term sheet for an exclusive…
Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program
On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…
Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19
On Jul. 20, 2020, Mateon Therapeutics announced the launch of its global observational study called ARTI-19, for Artemisinin…
Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell line
On Jul. 20, 2020, Innovation Pharma reported receiving new data from ongoing lab testing being conducted at a…
OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contract
On Jul. 20, 2020, BioReference Laboratories, an OPKO Health company, announced accepted an Indefinite Delivery Indefinite Quantity contract…
Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccines
On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…
Luminex received FDA Emergency Use Authorization for COVID-19 antibody test
On Jul. 20, 2020, Luminex announced the FDA had issued an Emergency Use Authorization for the company’s xMAPļ¾®…
HDT BIOļ¾s COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection
On Jul. 20, 2020, scientists at HDT Bio, PAI Life Sciences, and the University of Washington announced they…
HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials
On Jul. 19, 2020, HDT Bio announced co-development efforts with Gennova Biopharmaceuticals to start evaluating HDT-301, a COVID-19…
Novartis launched first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
On Jul. 16, 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC;…
RedHill Biopharma received approval for phase 2/3 COVID-19 study in Russia
On Jul. 16, 2020, RedHill Biopharma announced approval from the Ministry of Health of the Russian Federation for…
Heron Therapeutics announced initiation of phase 2 clinical study of CINVANTIļ¾® for treatment of COVID-19
On Jul. 16, 2020, Heron Therapeutics announced initiation of the GUARDS-1 Study, a Phase 2 clinical study evaluating…